نتایج جستجو برای: fasn

تعداد نتایج: 956  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Teresa Puig Carlos Turrado Bellinda Benhamú Helena Aguilar Joana Relat Silvia Ortega-Gutiérrez Gemma Casals Pedro F Marrero Ander Urruticoechea Diego Haro María Luz López-Rodríguez Ramon Colomer

PURPOSE: Fatty acid synthase (FASN) is overexpressed in human breast carcinoma. The natural polyphenol (-)-epigallocatechin-3-gallate blocks in vitro FASN activity and leads to apoptosis in breast cancer cells without any effects on carnitine palmitoyltransferase-1 (CPT-1) activity, and in vivo, does not decrease body weight. We synthesized a panel of new polyphenolic compounds and tested their...

2016
Timothy S. Heuer

Palmitate, the enzymatic product of fatty acid synthase (FASN), provides a substrate for the synthesis of longand short-chain fatty acids. Many recent studies have expanded our knowledge about the roles palmitate and lipid synthesis play in tumor cell biology beyond supporting energy metabolism and membrane building [1,2]. The recent article by Ventura and colleagues [3] described cell biology ...

2013
XING HUA LONG JIAN HUA MAO AI FEN PENG YANG ZHOU SHAN HU HUANG ZHI LI LIU

Numerous studies have recently suggested that miRNAs contribute to the development of various types of human cancer as well as to their invasive and metastatic capacities. The aim of this study was to investigate the functional significance of miR-424 and to identify its possible target genes in osteosarcoma (OS) cells. Previously, inhibition of fatty acid synthase (FASN) has been shown to supp...

2016
Javier A. Menendez Luciano Vellon Ingrid Espinoza Ruth Lupu

The angiogenic inducer CCN1 (Cysteine-rich 61, CYR61) is differentially activated in metastatic breast carcinomas. However, little is known about the precise mechanisms that underlie the pro-metastatic actions of CCN1. Here, we investigated the impact of CCN1 expression on fatty acid synthase (FASN), a metabolic oncogene thought to provide cancer cells with proliferative and survival advantages...

2010
María D Mayas Francisco J Ortega Manuel Macías-González Rosa Bernal Ricardo Gómez-Huelgas José M Fernández-Real Francisco J Tinahones

BACKGROUND Adipose tissue is a key regulator of energy balance playing an active role in lipid storage and may be a dynamic buffer to control fatty acid flux. Just like PPARgamma, fatty acid synthesis enzymes such as FASN have been implicated in almost all aspects of human metabolic alterations such as obesity, insulin resistance or dyslipemia. The aim of this work is to investigate how FASN an...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2016
Imran Ahmad Ernest Mui Laura Galbraith Rachana Patel Ee Hong Tan Mark Salji Alistair G Rust Peter Repiscak Ann Hedley Elke Markert Carolyn Loveridge Louise van der Weyden Joanne Edwards Owen J Sansom David J Adams Hing Y Leung

Prostate cancer (CaP) is the most common adult male cancer in the developed world. The paucity of biomarkers to predict prostate tumor biology makes it important to identify key pathways that confer poor prognosis and guide potential targeted therapy. Using a murine forward mutagenesis screen in a Pten-null background, we identified peroxisome proliferator-activated receptor gamma (Pparg), enco...

2016
Yuki Yasumoto Hirofumi Miyazaki Linda Koshy Vaidyan Yoshiteru Kagawa Majid Ebrahimi Yui Yamamoto Masaki Ogata Yu Katsuyama Hirokazu Sadahiro Michiyasu Suzuki Yuji Owada Arun Rishi

Cellular metabolic changes, especially to lipid metabolism, have recently been recognized as a hallmark of various cancer cells. However, little is known about the significance of cellular lipid metabolism in the regulation of biological activity of glioma stem cells (GSCs). In this study, we examined the expression and role of fatty acid synthase (FASN), a key lipogenic enzyme, in GSCs. In the...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014
Mart Dela Cruz Ramesh K Wali Laura K Bianchi Andrew J Radosevich Susan E Crawford Lisa Jepeal Michael J Goldberg Jaclyn Weinstein Navneet Momi Priya Roy Audrey H Calderwood Vadim Backman Hemant K Roy

BACKGROUND We have previously reported that colonic pericryptal microvascular blood flow is augmented in the premalignant colonic epithelium, highlighting the increased metabolic demand of the proliferative epithelium as a marker of field carcinogenesis. However, its molecular basis is unexplored. In this study, we assessed the expression of a regulator of the "lipogenic switch," fatty acid syn...

2016
Li Yang Fuquan Zhang Xin Wang Ying Tsai Kuang-Hsiang Chuang Peter C. Keng Soo Ok Lee Yuhchyau Chen

Cisplatin-resistant A549CisR and H157CisR cell lines were developed by treating parental A549 (A549P) and H157 (H157P) cells. These cisplatin-resistant cells showed slight growth retardation, but exhibited higher epithelial-mesenchymal transition (EMT) and increased metastatic potential compared to parental cells. We observed a highly up-regulated fatty acid synthase (FASN) level in A549CisR an...

2016
Sudeshna Goswami Neelam Sharma-Walia

The crosstalk between malignant and nonmalignant cells in the tumor microenvironment, as maneuvered by cytokines/chemokines, drives breast cancer progression. In our previous study, we discovered Osteoprotegerin (OPG) as one of the cytokines heavily secreted by breast cancer cells. We demonstrated that OPG is expressed and secreted at very high levels from the highly invasive breast cancer cell...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید